A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy
暂无分享,去创建一个
R. Braren | H. Friess | W. Weichert | E. Rummeny | G. Kaissis | F. Lohöfer | R. Schmid | Hsi-Yu Yen | H. Algül | K. Steiger | J. Siveke | Sebastian Ziegelmayer | A. Muckenhuber